Multiple subconjunctival bevacizumab for advanced primary pterygium.
Effectiveness of multiple subconjunctival bevacizumab injections in advanced primary pterygium was studied the first time. Treatment produced regression of pteryium and improvement of best-corrected visual acuity from 20/100 to 20/60 at 6-mont follow-up. Off-label short-term use of sbconjunctival bevaciumab is effective.